PTH and hyperphosphatemia: The two most important primary reasons to start cinacalcet were to reduce PTH in patients with hyperphosphatemia (56.3%, n = 174) or to reduce PTH in patients with normophosphatemia and normocalcemia (21.7%, n = 67; Figure S2).